Bhat Sudipta, Nagarajan Shanmugasundaram, Kumar Manoj, Murugkar Harshad V, Kalaiyarasu Semmannan, Venkatesh Govindarajulu, Tosh Chakradhar
ICAR-National Institute of High Security Animal Diseases, Anand Nagar, Bhopal, 462 022, India.
ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India.
Arch Virol. 2017 Feb;162(2):487-494. doi: 10.1007/s00705-016-3134-y. Epub 2016 Nov 3.
Highly pathogenic avian influenza (HPAI) is a major health concern worldwide. In this study, we focused on antigenic analysis of HPAI H5N1 viruses isolated from poultry in India between 2006 and 2015 comprising 25 isolates from four phylogenetic clades 2.2 (1 isolate), 2.2.2.1 (1 isolate), 2.3.2.1a (17 isolates) and 2.3.2.1c (6 isolates). Seven H5N1 isolates from all four clades were selected for production of chicken antiserum, and antigenic analysis was carried out by hemagglutination inhibition (HI) assay. HI data indicated antigenic divergence (6-21 fold reduction in cross-reactivity) between the two recently emerged clades 2.3.2.1a and 2.3.2.1c. These two clades are highly divergent (21-128 fold reduction in HI titre) from the earlier clades 2.2 /2.2.2.1 isolated in India. However, a maximum of 2-fold and 4-fold reduction in cross-reactivity was observed within the isolates of homologous clades 2.3.2.1c and 2.3.2.1a, respectively. The molecular basis of inter-clade antigenic divergence was examined in the haemagglutinin (HA) antigenic sites of the H5N1 virus. Amino acid changes at 8 HA antigenic sites were observed between clades 2.3.2.1a and 2.3.2.1c, whereas 20-23 substitutions were observed between clades 2.3.2.1a/2.3.2.1c and 2.2/2.2.2.1. Therefore, a systematic analysis of antigenic drift of the contemporary field isolates is a pre-requisite for determining the suitable strain(s) for vaccine candidature.
高致病性禽流感(HPAI)是全球主要的健康关注点。在本研究中,我们聚焦于2006年至2015年间从印度家禽中分离出的HPAI H5N1病毒的抗原分析,这些病毒包括来自四个系统发育分支2.2(1株)、2.2.2.1(1株)、2.3.2.1a(17株)和2.3.2.1c(6株)的25个分离株。从所有四个分支中选择了7株H5N1分离株用于制备鸡抗血清,并通过血凝抑制(HI)试验进行抗原分析。HI数据表明,最近出现的两个分支2.3.2.1a和2.3.2.1c之间存在抗原差异(交叉反应性降低6至21倍)。这两个分支与在印度分离出的早期分支2.2/2.2.2.1高度不同(HI效价降低21至128倍)。然而,在同源分支2.3.2.1c和2.3.2.1a的分离株中,交叉反应性分别最多降低了2倍和4倍。在H5N1病毒的血凝素(HA)抗原位点检查了分支间抗原差异的分子基础。在2.3.2.1a和2.3.2.1c分支之间观察到8个HA抗原位点的氨基酸变化,而在2.3.2.1a/2.3.2.1c和2.2/2.2.2.1分支之间观察到20至23个替换。因此,对当代现场分离株的抗原漂移进行系统分析是确定适合作为疫苗候选株的毒株的先决条件。